Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption independently of Insulin and Glycemia

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Familial Hypercholesterolemia and Risk of Peripheral Arterial Disease and Chronic Kidney Disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Hyperosmolar Duodenal Saline Infusion Lowers Circulating Ghrelin and Stimulates Intestinal Hormone Release in Young Men

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. l-Carnitine Improves Skeletal Muscle Fat Oxidation in Primary Carnitine Deficiency

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Cancer Incidence in Patients With Acromegaly: A Cohort Study and Meta-Analysis of the Literature

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Effects of Dapagliflozin on Volume Status When Added to Renin-Angiotensin System Inhibitors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Hyponatremia and metabolic bone disease in patients with epilepsy: A cross-sectional study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Mikkel B Christensen
  • Asger Lund
  • Salvatore Calanna
  • Niklas R Jørgensen
  • Jens J Holst
  • Tina Vilsbøll
  • Filip K Knop
Vis graf over relationer

Context: The gut hormone GIP causes postprandial insulin release and inhibits bone resorption assessed by carboxy-terminal collagen crosslinks (CTX).

Objective: To clarify if GIP affects biomarkers involved in bone homeostasis independently of insulin release and glycemic level.

Design: Randomized, double-blinded, cross-over study with 5 study days.

Patients: Ten lean male C-peptide-negative patients with type 1 diabetes.

Interventions: On 3 matched days with 'low glycemia' (i.e. plasma glucose clamped between 3-7 mmol/L for 120 minutes) we administered (IV) either GIP (4 pmol/kg/min), glucagon-like-peptide-1 (GLP-1) (1 pmol/kg/min) or placebo (saline); and on 2 matched days with 'high glycemia' (i.e. clamped at 12 mmol/L for 90 minutes) we administered (IV) either GIP (4 pmol/kg/min) or saline.

Main Outcome Measures: CTX, N-terminal propeptide of type 1 procollagen (P1NP), and PTH.

Results: During 'low glycemia': GIP progressively suppressed CTX from baseline by up to 59±18% compared to 24±10% during saline infusion (P<0.0001). Absolute values of P1NP and PTH did not differ between GIP and placebo days. During 'high glycemia': GIP suppressed CTX from baseline by up to 59±19% compared to 7±9% during saline infusion (P<0.0001). P1NP did not differ between GIP and placebo days. GIP suppressed PTH after 60 minutes compared to saline (P<0.01), but this difference disappeared after 90 minutes.

Conclusions: Short term GIP infusions robustly reduces bone resorption independently of endogenous insulin secretion and during both elevated and low plasma glucose levels, but has no effect on P1NP or PTH after 90 minutes.

OriginalsprogEngelsk
TidsskriftThe Journal of clinical endocrinology and metabolism
Vol/bind103
Udgave nummer1
Sider (fra-til)288-294
Antal sider7
ISSN0021-972X
DOI
StatusUdgivet - 2018

ID: 51975650